APA (7th ed.) Citation

RN, S., H, C., X, W., PH, F., N, R., SE, Y., . . . TH, D. (2025). Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345. Antioxidants (Basel, Switzerland), 14(12), . https://doi.org/10.3390/antiox14121479

Chicago Style (17th ed.) Citation

RN, Senguttuvan, et al. "Correction: Senguttuvan Et Al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345." Antioxidants (Basel, Switzerland) 14, no. 12 (2025). https://doi.org/10.3390/antiox14121479.

MLA (9th ed.) Citation

RN, Senguttuvan, et al. "Correction: Senguttuvan Et Al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345." Antioxidants (Basel, Switzerland), vol. 14, no. 12, 2025, https://doi.org/10.3390/antiox14121479.